전자처방전 시장 - 예측(2026-2031년)

The E-Prescribing market , with a 23.5% CAGR, is projected to increase from USD 2.381 billion in 2025 to USD 8.449 billion in 2031.

The e-prescribing market is a critical component of the ongoing digital transformation within the global healthcare sector. E-prescribing, the process of electronically generating and transmitting prescription orders from healthcare providers to pharmacies, represents a fundamental shift from traditional paper-based methods. This technology eliminates handwritten scripts, streamlines the medication management workflow, and directly interfaces with pharmacy systems. The core value proposition driving adoption centers on enhancing patient safety by reducing medication errors related to illegibility or incorrect dosing, improving operational efficiency within clinical practices, and facilitating better medication adherence and management. As healthcare systems worldwide prioritize digitization, the demand for integrated e-prescribing solutions is experiencing significant and sustained growth.

A primary catalyst for market expansion is the accelerating adoption of Electronic Health Records (EHRs) and broader healthcare digitalization initiatives. E-prescribing functionality is increasingly embedded as a core module within comprehensive EHR platforms, creating a natural pathway for adoption as providers implement these integrated systems. Government policies and incentive programs in many regions actively promote the use of certified EHR technology, which includes e-prescribing capabilities, to improve care quality and interoperability. This regulatory and institutional push, combined with the healthcare industry's strategic focus on connectivity and data-driven care, creates a powerful driver for e-prescribing implementation across ambulatory and inpatient settings.

Furthermore, the compelling economic and operational benefits of e-prescribing solutions fuel their adoption. These systems deliver tangible cost savings and workflow efficiencies by eliminating manual processes associated with paper prescriptions, such as printing, handling, and physical transmittal. They reduce administrative burdens on clinical staff, minimize time spent on pharmacy callbacks for clarification, and accelerate the prescription fulfillment process. For healthcare organizations operating under margin pressures, the return on investment from reduced errors, improved staff productivity, and enhanced patient throughput provides a strong financial rationale for deployment. The efficiency gains extend to pharmacies, fostering a more seamless and error-resistant medication supply chain.

Concurrent technological advancements are also propelling the market forward. The evolution of cloud-based platforms has made sophisticated e-prescribing solutions more accessible and scalable, particularly for smaller practices without extensive IT infrastructure. Integration with mobile applications enhances accessibility for providers and can improve patient engagement through features like electronic prescription delivery to smartphones. Modern e-prescribing systems offer advanced functionalities such as real-time benefit checks, drug interaction alerts, and formulary compliance tools, moving beyond simple electronic transmission to become active decision-support systems that improve prescribing accuracy and cost-effectiveness.

Geographically, North America is established as the leading market for e-prescribing solutions. This leadership position is attributed to a confluence of factors: a mature healthcare IT infrastructure, early and widespread EHR adoption, and a regulatory environment that has actively encouraged digital prescribing through legislation and standards. High awareness of the benefits among both providers and patients, coupled with the presence of major technology vendors and well-established health information networks, has cemented widespread integration into standard clinical practice. The region's market is characterized by a high degree of connectivity between prescribers and pharmacies, facilitated by national networks that ensure interoperability and secure data exchange.

The competitive landscape is comprised of several key player segments. Major EHR platform vendors, such as Epic Systems Corporation and Cerner Corporation, offer deeply integrated e-prescribing modules as part of their comprehensive clinical suites, leveraging their entrenched position in health system IT. Alongside these are best-of-breed and specialized e-prescribing solution providers, like DrFirst Inc., which focus on advanced medication history services, prescription drug monitoring program (PDMP) integration, and secure provider-pharmacy communication platforms. A critical enabler in the ecosystem is the health information network, exemplified by Surescripts, which operates the national infrastructure connecting prescribers, pharmacies, and payers to facilitate secure data exchange at scale.

Leading companies in the space continue to focus on enhancing interoperability, expanding clinical decision support, and integrating with a wider array of healthcare data sources. The strategic direction involves moving from a foundational prescription routing tool to an intelligent medication management platform. This evolution includes incorporating more comprehensive patient medication histories, streamlining prior authorization processes, and providing actionable analytics at the point of care. The market's trajectory is thus defined by its progression from a discrete efficiency tool to an indispensable component of connected, safe, and efficient medication management within modern digital healthcare frameworks.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2021 to 2025 & forecast data from 2026 to 2031
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.)

E-Prescribing Market Segmentation

• By Product
• Solutions
• Services
• By Delivery Mode
• Web-based
• On-premise
• Cloud-based
• By End-User
• Hospitals
• Physician Offices
• Pharmacies
• By Geography
• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. E-PRESCRIBING MARKET BY PRODUCT

• 5.1. Introduction
• 5.2. Solutions
• 5.3. Services

6. E-PRESCRIBING MARKET BY DELIVERY MODE

• 6.1. Introduction
• 6.2. Web-based
• 6.3. On-premise
• 6.4. Cloud-based

7. E-PRESCRIBING MARKET BY END-USER

• 7.1. Introduction
• 7.2. Hospitals
• 7.3. Physician Offices
• 7.4. Pharmacies

8. E-PRESCRIBING MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. USA
  • 8.2.2. Canada
  • 8.2.3. Mexico
• 8.3. South America
  • 8.3.1. Brazil
  • 8.3.2. Argentina
  • 8.3.3. Others
• 8.4. Europe
  • 8.4.1. Germany
  • 8.4.2. France
  • 8.4.3. United Kingdom
  • 8.4.4. Spain
  • 8.4.5. Others
• 8.5. Middle East and Africa
  • 8.5.1. Saudi Arabia
  • 8.5.2. UAE
  • 8.5.3. Others
• 8.6. Asia Pacific
  • 8.6.1. China
  • 8.6.2. India
  • 8.6.3. Japan
  • 8.6.4. South Korea
  • 8.6.5. Indonesia
  • 8.6.6. Thailand
  • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. Cerner Corporation
• 10.2. Veradigm LLC (Formerly AllScripts)
• 10.3. athenahealth
• 10.4. NextGen Healthcare, Inc.
• 10.5. McKesson Corporation
• 10.6. Practice Fusion, Inc (acquired by Veradigm LLC)
• 10.7. Surescripts LLC
• 10.8. DrFirst
• 10.9. Medical Information Technology, Inc. (MEDITECH)

11. APPENDIX

• 11.1. Currency
• 11.2. Assumptions
• 11.3. Base and Forecast Years Timeline
• 11.4. Key Benefits for the Stakeholders
• 11.5. Research Methodology
• 11.6. Abbreviations